Llwytho...
Anticoagulation Strategies in Patients With Cancer
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer, low molecular weight heparins have been preferred for treatment of VTE, whereas warfarin has been the standard anticoagulant for stroke preven...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Am Coll Cardiol |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957366/ https://ncbi.nlm.nih.gov/pubmed/30898209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.01.017 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|